Dynulta Tablet

Introduction

Dynulta is a prescription medication that contains Sucroferric oxyhydroxide as its active ingredient. It is available in tablet form and is primarily used for the treatment of certain kidney conditions, such as hyperphosphatemia in patients with chronic kidney disease (CKD) who are on dialysis.

Uses

Dynulta is prescribed to manage high levels of phosphate in the blood, a condition known as hyperphosphatemia, in patients with CKD who are undergoing dialysis. It helps to lower phosphate levels by binding to dietary phosphate in the gastrointestinal tract and preventing its absorption into the bloodstream.

Dosage and Administration

The dosage of Dynulta will be determined by your healthcare provider based on your individual needs and medical condition. Follow the prescribed dosage instructions carefully. The tablets should be swallowed whole with sufficient water, and they can be taken with or without food. Do not crush, chew, or break the tablets unless instructed to do so by your doctor.

Mechanism of Action

Sucroferric oxyhydroxide, the active ingredient in Dynulta, works by binding to dietary phosphate in the gastrointestinal tract. This prevents the phosphate from being absorbed into the bloodstream and helps to lower phosphate levels in the body. By reducing the amount of phosphate in the blood, it helps to manage hyperphosphatemia in patients with CKD who are on dialysis.

Side Effects

Common side effects may include diarrhea, constipation, nausea, vomiting, and stomach discomfort. These side effects are generally mild and temporary. However, if any of these side effects persist or worsen, consult your healthcare provider.

In rare cases, Dynulta may cause more serious side effects, such as severe constipation, intestinal blockage, or allergic reactions. If you experience any signs of a severe allergic reaction, such as rash, itching, swelling, dizziness, or difficulty breathing, seek immediate medical attention.

Drug Interactions

inform your healthcare provider about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. Some medications may interact with Dynulta and affect its effectiveness or increase the risk of side effects. Common drug interactions may include certain antibiotics, antacids, and iron supplements. Your healthcare provider will carefully consider these potential interactions when prescribing Dynulta.

Precautions

Before starting treatment with Dynulta, inform your healthcare provider about any medical conditions you have, especially if you have a history of bowel obstruction or if you are allergic to any of the ingredients in the medication.

Additionally, let your healthcare provider know about all the medications you are currently taking, including prescription, over-the-counter, and herbal products, as well as any substances you may be using, such as alcohol or tobacco. These can potentially interact with Dynulta and affect its safety and effectiveness.

Storage

Dynulta should be stored at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not use Dynulta after the expiration date printed on the packaging. If you have any unused or expired medication, consult your pharmacist or healthcare provider for proper disposal instructions.

Patient Tips

• Take Dynulta exactly as prescribed by your healthcare provider.
• Swallow the tablets whole with sufficient water, and do not crush, chew, or break them unless instructed to do so.
• Follow any dietary restrictions or guidelines given by your healthcare provider.
• If you experience persistent or bothersome side effects, consult your healthcare provider.
• Keep all follow-up appointments with your healthcare provider to monitor your condition and response to the medication.
• If you have any questions or concerns about Dynulta or its use, consult your healthcare provider for clarification.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Velphoro 125 mg oral powder in sachet (Health Professionals SmPC) Available at:
• Sucroferric oxyhydroxide (Drugs.com) [Accessed 12 Jun. 2024] (online) Available at:
• sucroferric oxyhydroxide tablet, chewable (RX) [Accessed 3 Jun. 2024] (online) Available at:
• LactMed: Drugs and Lactation Database (National Library of Medicine) [Accessed 1 Jun. 2024] (online) Available at:
• [No authors listed] Sucroferric Oxyhydroxide. 2024 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. [Accessed 19 Jun. 2024] Available at: